1466.0000 -28.60 (-1.91%)
NSE Jun 06, 2025 15:31 PM
Volume: 10,194
 

1466.00
-1.91%
Prabhudas Lilladhar
JLHL's Q4 consolidated EBITDA grew by 26% YoY (4% QoQ) to Rs783mn, largely in line with our estimates, aided by higher ARPOB. Its operational efficiency has been strong in the competitive markets of MMR. The company reported revenue/EBITDA CAGR of 20%/25% over FY22-25. Given its expansion plans, scale-up in occupancy and improving margins, growth momentum is expected to sustain over the medium term. We believe strategic greenfield expansions in densely populated micro-markets of western regions...
Jupiter Life Line Ho.. has an average target of 1690.00 from 3 brokers.
More from Jupiter Life Line Hospitals Ltd.
Recommended